Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2026-01-13 @ 3:35 AM
Study NCT ID:
NCT04782258
Status:
RECRUITING
Last Update Posted:
2025-09-30
First Post:
2021-02-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Autosomal Recessive Polycystic Kidney (ARPKD) | View |